Predictions
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.17
21.09.20
21.09.20
€12.00
02.11.20
02.11.20
-24.15%
02.11.20
02.11.20
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.92
20.09.20
20.09.20
-
04.11.21
04.11.21
6.78%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Very low/no dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€91.29
19.09.20
19.09.20
-
04.11.21
04.11.21
16.11%
27.11.20
27.11.20
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Immunomedics Inc.
Start price
Target price
Perf. (%)
€72.02
19.09.20
19.09.20
-
04.11.21
04.11.21
3.10%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.00
19.09.20
19.09.20
-
04.11.21
04.11.21
-26.89%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Vaxart Inc.
Start price
Target price
Perf. (%)
€4.22
09.09.20
09.09.20
€8.00
04.11.21
04.11.21
42.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€47.63
08.09.20
08.09.20
-
19.09.20
19.09.20
-4.25%
19.09.20
19.09.20
Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.60
08.09.20
08.09.20
€7.00
21.09.20
21.09.20
46.07%
21.09.20
21.09.20
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
Trillium Therapeutics
Start price
Target price
Perf. (%)
€8.28
07.09.20
07.09.20
-
04.11.21
04.11.21
-21.91%
15.07.21
15.07.21
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€128.00
06.09.20
06.09.20
€125.00
04.11.21
04.11.21
-3.25%
06.11.20
06.11.20
Future proof or reliable business model
Higher risks for its business
Risky Investment
Verastem Inc.
Start price
Target price
Perf. (%)
€11.94
06.09.20
06.09.20
€24.00
28.09.20
28.09.20
7.41%
28.09.20
28.09.20
Could be very worthwhile Investment >20% year
Fair valuation
Increased challenges to pay loans and raise capital
Risky balance sheet
Novavax Inc.
Start price
Target price
Perf. (%)
€80.99
05.09.20
05.09.20
-
04.11.21
04.11.21
74.71%
03.06.21
03.06.21
Could be very worthwhile Investment >20% year
Grifols S.A.
Start price
Target price
Perf. (%)
€22.77
01.09.20
01.09.20
€30.00
04.11.21
04.11.21
-18.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Uniqure B.V.
Start price
Target price
Perf. (%)
€32.45
29.08.20
29.08.20
€40.00
04.11.21
04.11.21
-7.18%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.32
26.08.20
26.08.20
€50.00
08.10.20
08.10.20
-2.68%
08.10.20
08.10.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.32
26.08.20
26.08.20
€50.00
08.10.20
08.10.20
-2.68%
08.10.20
08.10.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.32
26.08.20
26.08.20
€50.00
08.10.20
08.10.20
-2.68%
08.10.20
08.10.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Verastem Inc.
Start price
Target price
Perf. (%)
€13.13
25.08.20
25.08.20
€25.20
04.11.21
04.11.21
120.37%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.93
25.08.20
25.08.20
€25.62
03.09.20
03.09.20
-2.45%
03.09.20
03.09.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.93
25.08.20
25.08.20
€25.62
03.09.20
03.09.20
-2.45%
03.09.20
03.09.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Amgen Inc.
Start price
Target price
Perf. (%)
€207.40
25.08.20
25.08.20
€225.00
21.09.20
21.09.20
-1.23%
21.09.20
21.09.20
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Amgen Inc.
Start price
Target price
Perf. (%)
€207.40
25.08.20
25.08.20
€225.00
21.09.20
21.09.20
-1.23%
21.09.20
21.09.20
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating